Cipla News
Most Popular Cipla Story
Cipla offers generic Tamiflu for pandemic
Cipla, India's second-biggest drugmaker by market value, said it can supply 1.5 million doses of generic Tamiflu drugs to help fight an outbreak of swine flu. The company sells its copycat antiviral... Read more...
Latest Headlines
- January 4, 2010
- December 1, 2009
- August 18, 2009
- May 14, 2009
- April 27, 2009
- April 21, 2008
- April 2, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
